Thymic carcinoma other diagnostic studies: Difference between revisions
No edit summary |
Marjan Khan (talk | contribs) No edit summary |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thymic carcinoma}} | {{Thymic carcinoma}} | ||
{{CMG}}; {{AE}} {{ | {{CMG}}; {{AE}} {{Marjan}} | ||
==Overview== | ==Overview== | ||
Other diagnostic studies for thymic carcinoma include immunohistochemistry. | Other diagnostic studies for thymic carcinoma include immunohistochemistry. For squamous cell carcinoma subtype, the epithelial cells are immunoreactive to CD5, CD70, and CD117. In contrast with thymomas that are negative to CD5. However, for squamous cell carcinomas of other locations, the CD5 and CD70 are negative, which means that this technique is useful to confirm the thymic origin of the tumor. | ||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
===Immunohistochemistry=== | ===Immunohistochemistry=== | ||
For | For squamous cell carcinoma subtype, the epithelial cells are immunoreactive to CD5, CD70, and CD117. In contrast with thymomas that are negative to CD5. However, for squamous cell carcinomas of other locations, the CD5 and CD70 are negative, which means that this technique is useful to confirm the thymic origin of the tumor. <ref>{{Cite web | last = | first = | title =http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/BB10.pdf | url = http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/BB10.pdf | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
| Line 14: | Line 15: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 15:00, 28 June 2019
|
Thymic Carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Thymic carcinoma other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Thymic carcinoma other diagnostic studies |
|
Risk calculators and risk factors for Thymic carcinoma other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]
Overview
Other diagnostic studies for thymic carcinoma include immunohistochemistry. For squamous cell carcinoma subtype, the epithelial cells are immunoreactive to CD5, CD70, and CD117. In contrast with thymomas that are negative to CD5. However, for squamous cell carcinomas of other locations, the CD5 and CD70 are negative, which means that this technique is useful to confirm the thymic origin of the tumor.
Other Diagnostic Studies
Immunohistochemistry
For squamous cell carcinoma subtype, the epithelial cells are immunoreactive to CD5, CD70, and CD117. In contrast with thymomas that are negative to CD5. However, for squamous cell carcinomas of other locations, the CD5 and CD70 are negative, which means that this technique is useful to confirm the thymic origin of the tumor. [1]
References
- ↑ "http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/BB10.pdf" (PDF). External link in
|title=(help)